Westlake Chem Partners LP (WLKP) Position Held by Salient Capital Advisors Llc

Investors sentiment increased to 0.94 in 2019 Q1. Its up 0.11, from 0.83 in 2018Q4. It improved, as 40 investors sold WLKP shares while 86 reduced holdings. 44 funds opened positions while 75 raised stakes. 44.67 million shares or 0.65% less from 44.97 million shares in 2018Q4 were reported. Synovus Financial Corporation owns 5 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.01% or 18,941 shares. Moreover, Balyasny Asset Mgmt Ltd has 0.05% invested in Westlake Chemical Partners LP (NYSE:WLKP) for 110,230 shares. Macquarie Group owns 600 shares or 0% of their US portfolio. Shapiro Cap Management Ltd Liability holds 0% or 57,679 shares in its portfolio. Sumitomo Mitsui Trust Incorporated holds 169,658 shares or 0.01% of its portfolio. Wellington Mgmt Grp Llp invested 0% of its portfolio in Westlake Chemical Partners LP (NYSE:WLKP). Rhumbline Advisers holds 0.01% or 38,145 shares in its portfolio. Legal General Gru Inc Pcl holds 209,581 shares. New York-based Mackay Shields Ltd Liability Corp has invested 0.02% in Westlake Chemical Partners LP (NYSE:WLKP). Hudock Grp Limited Liability Corp accumulated 0% or 46 shares. Regions reported 0% of its portfolio in Westlake Chemical Partners LP (NYSE:WLKP). State Street owns 927,883 shares. Moreover, J Goldman And Communications LP has 0.02% invested in Westlake Chemical Partners LP (NYSE:WLKP) for 6,023 shares. Price Michael F has invested 0.77% of its portfolio in Westlake Chemical Partners LP (NYSE:WLKP).

Since March 29, 2019, it had 1 insider purchase, and 0 sales for $30.00 million activity.

Salient Capital Advisors Llc increased its stake in Westlake Chem Partners Lp (WLKP) by 1935.8% based on its latest 2019Q1 regulatory filing with the SEC. Salient Capital Advisors Llc bought 504,064 shares as the company’s stock rose 4.96% . The institutional investor held 530,103 shares of the major chemicals company at the end of 2019Q1, valued at $11.89M, up from 26,039 at the end of the previous reported quarter. Salient Capital Advisors Llc who had been investing in Westlake Chem Partners Lp for a number of months, seems to be bullish on the $766.55M market cap company. The stock decreased 0.32% or $0.07 during the last trading session, reaching $21.63. About 22,159 shares traded. Westlake Chemical Partners LP (NYSE:WLKP) has declined 7.30% since September 11, 2018 and is downtrending. It has underperformed by 7.30% the S&P500.

Salient Capital Advisors Llc, which manages about $5.02B and $4.28 billion US Long portfolio, decreased its stake in Semgroup Corp (NYSE:SEMG) by 2.57M shares to 1.37M shares, valued at $20.23M in 2019Q1, according to the filing. It also reduced its holding in Kinder Morgan Inc Del (NYSE:KMI) by 1.79M shares in the quarter, leaving it with 3.19M shares, and cut its stake in Macquarie Infrastructure Cor (NYSE:MIC).

More notable recent Westlake Chemical Partners LP (NYSE:WLKP) news were published by: Businesswire.com which released: “Westlake Chemical Partners Announce Second Quarter 2019 Earnings Conference Call – Business Wire” on July 23, 2019, also Businesswire.com with their article: “Westlake Chemical Partners LP Announces Fourth Quarter Distribution – Business Wire” published on January 25, 2019, Businesswire.com published: “Westlake Announces Increase in Target Distribution Thresholds for Incentive Distribution Rights (IDRs) of Westlake Chemical Partners LP – Business Wire” on July 30, 2018. More interesting news about Westlake Chemical Partners LP (NYSE:WLKP) were released by: Finance.Yahoo.com and their article: “Is Cass Information Systems (CASS) A Good Stock To Buy? – Yahoo Finance” published on May 09, 2019 as well as Seekingalpha.com‘s news article titled: “Westlake Chemical Partners – Not Your Usual MLP With A 6% Yield – Seeking Alpha” with publication date: October 16, 2015.

Westlake Chemical Partners LP (NYSE:WLKP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.